Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Harbron

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Statistics in Medicine|July 16, 2016
An adaptive design for updating the threshold value of a continuous biomarkerAmy V Spencer, Chris Harbron, Adrian Mander, et al.
Pharmaceutical Statistics|August 3, 2013
Investigation of the robustness of two models for assessing synergy in pre-clinical drug combination studiesAnne Whitehead, Ting-Li Su, Helene Thygesen, et al.
British Journal of Clinical Pharmacology|November 1, 2014
Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitorSimon Lea, Chris Harbron, Naimat Khan, et al.
JCO Clinical Cancer Informatics|November 21, 2025
Meta-Analysis of Bias in Non-Small Cell Lung Cancer External Control Arms That Use Real-World Progression-Free Survival as the End PointSanaa Bahmane, Chris Harbron, Devin Incerti, et al.
Pharmaceutical Statistics|April 28, 2021
The use of external controls: To what extent can it currently be recommended?Hans Ulrich Burger, Christoph Gerlinger, Chris Harbron, et al.
Scientific Reports|October 8, 2024
Deep learning as Ricci flowAnthony Baptista, Alessandro Barp, Tapabrata Chakraborti, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 25, 2020
P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cellsSimon Lea, Jian Li, Jonathan Plumb, et al.
Eclinicalmedicine|June 11, 2025
Clinicians must participate in the development of multimodal AIChristopher R S Banerji, Aroon Bhardwaj Shah, Ben Dabson, et al.
Pharmaceutical Statistics|December 14, 2011
A statistician's perspective on biomarkers in drug developmentMartin Jenkins, Aiden Flynn, Trevor Smart, et al.
Genetic Epidemiology|January 21, 2010
Optimizing the power of genome-wide association studies by using publicly available reference samples to expand the control groupJoanna J Zhuang, Krina Zondervan, Fredrik Nyberg, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Statistics in Medicine|July 16, 2016
An adaptive design for updating the threshold value of a continuous biomarkerAmy V Spencer, Chris Harbron, Adrian Mander, et al.
Pharmaceutical Statistics|August 3, 2013
Investigation of the robustness of two models for assessing synergy in pre-clinical drug combination studiesAnne Whitehead, Ting-Li Su, Helene Thygesen, et al.
British Journal of Clinical Pharmacology|November 1, 2014
Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitorSimon Lea, Chris Harbron, Naimat Khan, et al.
JCO Clinical Cancer Informatics|November 21, 2025
Meta-Analysis of Bias in Non-Small Cell Lung Cancer External Control Arms That Use Real-World Progression-Free Survival as the End PointSanaa Bahmane, Chris Harbron, Devin Incerti, et al.
Pharmaceutical Statistics|April 28, 2021
The use of external controls: To what extent can it currently be recommended?Hans Ulrich Burger, Christoph Gerlinger, Chris Harbron, et al.
Scientific Reports|October 8, 2024
Deep learning as Ricci flowAnthony Baptista, Alessandro Barp, Tapabrata Chakraborti, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 25, 2020
P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cellsSimon Lea, Jian Li, Jonathan Plumb, et al.
Eclinicalmedicine|June 11, 2025
Clinicians must participate in the development of multimodal AIChristopher R S Banerji, Aroon Bhardwaj Shah, Ben Dabson, et al.
Pharmaceutical Statistics|December 14, 2011
A statistician's perspective on biomarkers in drug developmentMartin Jenkins, Aiden Flynn, Trevor Smart, et al.
Genetic Epidemiology|January 21, 2010
Optimizing the power of genome-wide association studies by using publicly available reference samples to expand the control groupJoanna J Zhuang, Krina Zondervan, Fredrik Nyberg, et al.
Pageof 4